Featured Research

from universities, journals, and other organizations

New Kidney Disease Drug Saves Lives At Low Cost

Date:
December 3, 2005
Source:
Blackwell Publishing Ltd.
Summary:
A recent study has found that sevelamer (Renagel) is having a positive long term clinical and economic effect when used on hemodialysis patients. This study, undertaken by the Caro Research Institute in Concord, MA and published in Value in Health, examined the long-term consequences associated with one year of sevelamer use.

A recent study has found that sevelamer (Renagelฎ) is having a positive long term clinical and economic effect when used on hemodialysis patients. This study, undertaken by the Caro Research Institute in Concord, MA and published in Value in Health, examined the long-term consequences associated with one year of sevelamer use.

Related Articles


"The safety and efficacy of sevelamer and its ability to attenuate the progression of calcification have been well documented in a seminal clinical study, but the study was not designed to assess the longer-term implications," says Krista Huybrechts who led the study.

Huybrechts' team developed a simulation model based on the best available evidence to date, and estimated that in the long-term, patients on sevelamer have a 12% lower cardiovascular risk than those on calcium binders. The cost savings accrued due to avoiding cardiovascular events largely offset the higher drug cost, leading to a very favorable cost-effectiveness ratio of about $2,200 of increased cost per life year gained.

The results of this study now allow health policy makers and payers to understand the value of sevelamer in the long-term where it could not have been done from the clinical study alone.

Close to 500,000 Americans suffer from Stage V chronic kidney disease (CKD) and have a 10-20 times higher risk of cardiovascular mortality than the general population.

###

This study is published in Value in Health.

Krista Huybrechts, MS, is a Senior Researcher at the Caro Research Institute in Concord, MA, USA, which specializes in epidemiology and health economics. Prior to joining Caro Research in 1997, Krista held several positions in health economics/outcomes research at the worldwide headquarters of Janssen Pharmaceutica (J&J) in Belgium. Much of her work in recent years has focused on quantifying the clinical and economic implications of vascular calcifications in patients with ESRD.

About Value in Health
As the official publication of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), Value in Health provides a scientific forum for communicating health economics and outcomes research methods and findings, furthering ISPOR's vision that "society allocate scarce health care resources wisely, fairly, and efficiently." It is a multidisciplinary peer-reviewed journal reporting on evaluations of medical technologies including pharmaceuticals, biologics, devices, procedures, and other health care interventions.

About Blackwell Publishing
Blackwell Publishing is the world's leading society publisher, partnering with more than 600 academic and professional societies. Blackwell publishes over 750 journals annually and, to date has published close to 6,000 text and reference books, across a wide range of academic, medical, and professional subjects.


Story Source:

The above story is based on materials provided by Blackwell Publishing Ltd.. Note: Materials may be edited for content and length.


Cite This Page:

Blackwell Publishing Ltd.. "New Kidney Disease Drug Saves Lives At Low Cost." ScienceDaily. ScienceDaily, 3 December 2005. <www.sciencedaily.com/releases/2005/12/051202133842.htm>.
Blackwell Publishing Ltd.. (2005, December 3). New Kidney Disease Drug Saves Lives At Low Cost. ScienceDaily. Retrieved November 25, 2014 from www.sciencedaily.com/releases/2005/12/051202133842.htm
Blackwell Publishing Ltd.. "New Kidney Disease Drug Saves Lives At Low Cost." ScienceDaily. www.sciencedaily.com/releases/2005/12/051202133842.htm (accessed November 25, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Tuesday, November 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

From Popcorn To Vending Snacks: FDA Ups Calorie Count Rules

Newsy (Nov. 25, 2014) — The US FDA is announcing new calorie rules on Tuesday that will require everywhere from theaters to vending machines to include calorie counts. Video provided by Newsy
Powered by NewsLook.com
Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Daily Serving Of Yogurt Could Reduce Risk Of Type 2 Diabetes

Newsy (Nov. 25, 2014) — Need another reason to eat yogurt every day? Researchers now say it could reduce a person's risk of developing type 2 diabetes. Video provided by Newsy
Powered by NewsLook.com
Madagascar Working to Contain Plague Outbreak

Madagascar Working to Contain Plague Outbreak

AFP (Nov. 24, 2014) — Madagascar said Monday it is trying to contain an outbreak of plague -- similar to the Black Death that swept Medieval Europe -- that has killed 40 people and is spreading to the capital Antananarivo. Duration: 00:42 Video provided by AFP
Powered by NewsLook.com
Are Female Bosses More Likely To Be Depressed?

Are Female Bosses More Likely To Be Depressed?

Newsy (Nov. 24, 2014) — A new study links greater authority with increased depressive symptoms among women in the workplace. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins